CHARLES KING: Open Payments
NPI 1790134948 · BOONEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,858 in 96 payments from 11 companies in 2025. Trend: 2023 $164 · 2024 $861 · 2025 $1,858
Food & beverage: $1,846Education: $12
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 33 | $614 |
| ABBVIE INC. | 27 | $377 |
| Vanda Pharmaceuticals Inc. | 13 | $250 |
| Alkermes, Inc. | 10 | $175 |
| Janssen Pharmaceuticals, Inc | 2 | $137 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 4 | $63 |
| Almatica Pharma LLC | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
Products named: CAPLYTA, VRAYLAR, FANAPT, LYBALVI, SPRAVATO, Auvelity, REXULTI, COBENFY.
Industry payments across KY — which companies pay providers there.
